Eben Tessari - 04 Apr 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role: CHIEF OPERATING OFFICER
Signature: /s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol: KNSA
Transactions as of: 04 Apr 2024
Net transactions value: -$14,338
Form type: 4
Filing time: 08 Apr 2024, 17:17:17 UTC
Previous filing: 03 Apr 2024
Next filing: 29 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KNSA	Class A Common Share	Options Exercise		+2,726	+2.2%		126,825	08 Apr 2024	Direct	F1
transaction	KNSA	Class A Common Share	Tax liability	$14,338	-801	-0.63%	$17.90	126,024	08 Apr 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KNSA	Share Option	Award	$0	+36,300		$0.000000	36,300	04 Apr 2024	Class A Common Share	36,300	$18.06	Direct	F2
transaction	KNSA	Performance Share Unit	Award	$0	+5,585		$0.000000	5,585	04 Apr 2024	Class A Common Share	5,585		Direct	F3, F4
transaction	KNSA	Restricted Share Unit	Award	$0	+6,981	+131%	$0.000000	12,299	04 Apr 2024	Class A Common Share	6,981		Direct	F1, F5
transaction	KNSA	Restricted Share Unit	Options Exercise	$0	-2,726	-22%	$0.000000	9,573	08 Apr 2024	Class A Common Share	2,726		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F2	The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal month installments thereafter. The vesting commencement date is April 1, 2024.
F3	Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Common Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.
F4	Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Common Share of the Issuer no later than January 30, 2027, unless such date falls on a non-business date, in which case the next business date shall apply.
F5	The RSUs vest over a four year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter.
F6	The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.